GRIN2A and Parkinson disease: The authors considered it to be biologically plausible that GRIN2A plays a role in PD through an interaction with caffeinated coffee and suggested that GRIN2A genotypes may be a useful biomarker for pharmacogenetic studies on prevention and treatment in PD.